\-\ Texto\\:\\ \ \(0\)\
\-\ pe\\ was\\ non\\-contributory\\.\ \(0\)\
\-\ ct\\:\\ \\ \\ single\\ transverse\\ section\\ through\\ the\\ liver\\ with\\ iv\\ contrast\\.\\ \\ multiple\\ smooth\\-contoured\\ hepatic\\ lesions\\ of\\ higher\\ attenuation\\ than\\ the\\ surrounding\\ hepatic\\ parenchyma\\ are\\ noted\\ in\\ the\\ left\\ lobe\\.\\ \\ one\\ extremely\\ large\\ lesion\\,\\ which\\ abuts\\ the\\ hepatic\\ capsule\\,\\ is\\ of\\ particular\\ note\\ because\\ of\\ its\\ size\\.\\ \\ there\\ is\\ no\\ evidence\\ of\\ intra\\-lesion\\ scarring\\ or\\ calcification\\ noted\\.\ \(0\)\
\-\ us\\:\\ \\ single\\ longitudinal\\ image\\ of\\ liver\\ showing\\ hypoechoic\\ regions\\ with\\ smooth\\ margins\\ consistent\\ with\\ findings\\ on\\ ct\\.\\ \\ single\\ doppler\\ enhanced\\ transverse\\ image\\ of\\ same\\ hepatic\\ region\\ showing\\ blood\\ flow\\ to\\ the\\ largest\\ hypoechoic\\ region\\ of\\ liver\\.\\ \\ these\\ findings\\ suggests\\ vascularization\\ of\\ a\\ large\\ hepatic\\ mass\\ with\\ multiple\\ non\\-vascularized\\ smaller\\ satellite\\ masses\\.\ \(0\)\
\-\ hepatocellular\\ carcinoma\\ confirmed\\ on\\ us\\-guided\\ needle\\ biopsy\\.\ \(0\)\
\-\ \\<li\\>hepatocellular\\ carcinoma\ \(0\)\
\-\ \\<li\\>focal\\ nodular\\ hyperplasia\ \(0\)\
\-\ \\<li\\>hepatic\\ adenoma\ \(0\)\
\-\ \\<li\\>hemangioma\\ \ \(0\)\
\-\ \\<li\\>focal\\ fat\ \(0\)\
\-\ \\<li\\>focal\\ confluent\\ fibrosis\ \(0\)\
\-\ \\<li\\>primary\\ hepatic\\ lymphoma\ \(0\)\
\-\ \\<li\\>fibrolamellar\\ carcinoma\ \(0\)\
\-\ \\<li\\>angiosarcoma\ \(0\)\
\-\ \\<li\\>metastasis\ \(3\)\
\-\ h\\/o\\ hepatitis\\ c\\.\ \(0\)\
\-\ when\\ a\\ mass\\-like\\ lesion\\ in\\ the\\ liver\\ is\\ observed\\ on\\ imaging\\,\\ the\\ next\\ step\\ is\\ to\\ attempt\\ determining\\ which\\ diagnosis\\ best\\ fits\\ the\\ given\\ radiologic\\ findings\\.\\ given\\ the\\ findings\\ noted\\ above\\,\\ focal\\ confluent\\ fibrosis\\ \\(fcf\\)\\,\\ focal\\ fat\\,\\ and\\ hemangioma\\ can\\ be\\ removed\\ from\\ the\\ differential\\.\\ \\ fcf\\ tends\\ to\\ be\\ of\\ equal\\ or\\ slightly\\ lower\\ attenuation\\ as\\ surrounding\\ normal\\ parenchyma\\ on\\ iv\\ contrast\\-enhanced\\ ct\\.\\ \\ focal\\ fat\\ will\\ be\\ of\\ low\\ attenuation\\ similar\\ to\\ subcutaneous\\ fat\\ on\\ ct\\.\\ \\ the\\ benign\\ lesion\\,\\ hemangioma\\,\\ will\\ attenuate\\ similar\\ to\\ blood\\ and\\ will\\ display\\ increased\\ attentuation\\ on\\ enhancement\\.\\ \\ however\\,\\ when\\ contrast\\ is\\ added\\ to\\ enhance\\,\\ the\\ hemangioma\\ will\\ exhibit\\ delayed\\ enhancement\\ in\\ a\\ centripetal\\ pattern\\,\\ unlike\\ the\\ \\‚\\Ä\\úinstant\\‚\\Ä\\ù\\ and\\ complete\\ enhancement\\ of\\ the\\ lesions\\ shown\\ above\\.\\ \\ enhancement\\ is\\ delayed\\ secondary\\ to\\ the\\ relatively\\ low\\ flow\\ state\\ within\\ the\\ lesion\\.\\ \\ primary\\ hepatic\\ lymphoma\\ usually\\ appears\\ multilobulated\\ and\\ poorly\\ enhancing\\ on\\ ct\\.\\ \\ fibrolamellar\\ carcinomas\\ are\\ hyperechoic\\ lesions\\ on\\ us\\ and\\ often\\ display\\ punctate\\ calcifications\\ and\\ low\\ attenuation\\ on\\ enhanced\\ ct\\.\\ \\ metastases\\ will\\ most\\ commonly\\ show\\ scattered\\ small\\ lesions\\ throughout\\ the\\ hepatic\\ parenchyma\\ rather\\ than\\ the\\ large\\ lesion\\ depicted\\ in\\ the\\ attached\\ ct\\ and\\ us\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ li\\:\\ 0\\.11644088355307373\ \(0\)\
\-\ \\<\\:\\ 0\\.08434950198214297\ \(0\)\
\-\ hepatic\\:\\ 0\\.08213925617967803\ \(0\)\
\-\ \\>\\:\\ 0\\.07261297991479704\ \(0\)\
\-\ fcf\\:\\ 0\\.04509216585149104\ \(0\)\
\-\ hemangioma\\:\\ 0\\.03906195550079165\ \(0\)\
\-\ focal\\:\\ 0\\.03745002973102407\ \(0\)\
\-\ attenuation\\:\\ 0\\.03514701862328429\ \(0\)\
\-\ will\\:\\ 0\\.03418773680791742\ \(0\)\
\-\ fibrolamellar\\:\\ 0\\.0315931513777557\ \(0\)\
\-\ display\\:\\ 0\\.03091012635154331\ \(0\)\
\-\ liver\\:\\ 0\\.030140373512355233\ \(0\)\
\-\ confluent\\:\\ 0\\.028836136028739398\ \(0\)\
\-\ parenchyma\\:\\ 0\\.02792354494674682\ \(0\)\
\-\ us\\:\\ 0\\.027501865527712877\ \(0\)\
\-\ fat\\:\\ 0\\.026587338341500087\ \(0\)\
\-\ single\\:\\ 0\\.026575398648264182\ \(0\)\
\-\ hepatocellular\\:\\ 0\\.02518515665399423\ \(0\)\
\-\ enhancement\\:\\ 0\\.023432110139366098\ \(0\)\
\-\ lesions\\:\\ 0\\.023402153517585143\ \(0\)\
\-\ smooth\\-contoured\\:\\ 0\\.02254608292574552\ \(0\)\
\-\ intra\\-lesion\\:\\ 0\\.02254608292574552\ \(0\)\
\-\ non\\-vascularized\\:\\ 0\\.02254608292574552\ \(0\)\
\-\ lesion\\:\\ 0\\.022257739462921415\ \(0\)\
\-\ ct\\:\\ 0\\.02139929814256854\ \(0\)\
\-\ vascularization\\:\\ 0\\.020773327988252054\ \(0\)\
\-\ instant\\:\\ 0\\.020773327988252054\ \(0\)\
\-\ showing\\:\\ 0\\.020116196938005766\ \(0\)\
\-\ hypoechoic\\:\\ 0\\.019926023008380426\ \(0\)\
\-\ us\\-guided\\:\\ 0\\.0197363328268501\ \(0\)\
\-\ attenuate\\:\\ 0\\.0197363328268501\ \(0\)\
\-\ attentuation\\:\\ 0\\.0197363328268501\ \(0\)\
\-\ fibrosis\\:\\ 0\\.01946231779984779\ \(0\)\
\-\ enhanced\\:\\ 0\\.018703136187989616\ \(0\)\
\-\ findings\\:\\ 0\\.01860702747611212\ \(0\)\
\-\ carcinoma\\:\\ 0\\.01858256524308849\ \(0\)\
\-\ low\\:\\ 0\\.018231468436315085\ \(0\)\
\-\ centripetal\\:\\ 0\\.01796357788935663\ \(0\)\
\-\ delayed\\:\\ 0\\.017790180789080207\ \(0\)\
\-\ satellite\\:\\ 0\\.017569330626371317\ \(0\)\
\-\ transverse\\:\\ 0\\.017526581555754463\ \(0\)\
\-\ similar\\:\\ 0\\.017144177078981526\ \(0\)\
\-\ depicted\\:\\ 0\\.016926582727954678\ \(0\)\
\-\ on\\:\\ 0\\.016662452970048217\ \(0\)\
\-\ step\\:\\ 0\\.01641335844288524\ \(0\)\
\-\ fits\\:\\ 0\\.01641335844288524\ \(0\)\
\-\ above\\:\\ 0\\.016020146581216452\ \(0\)\
\-\ multilobulated\\:\\ 0\\.015986110144513968\ \(0\)\
\-\ iv\\:\\ 0\\.01595102269801071\ \(0\)\
\-\ noted\\:\\ 0\\.015540316023932944\ \(0\)\
\-\ abuts\\:\\ 0\\.015455063175771656\ \(0\)\
\-\ added\\:\\ 0\\.015455063175771656\ \(0\)\
\-\ mass\\-like\\:\\ 0\\.015300012992097909\ \(0\)\
\-\ given\\:\\ 0\\.01498421684151582\ \(0\)\
\-\ angiosarcoma\\:\\ 0\\.014884363556042219\ \(0\)\
\-\ exhibit\\:\\ 0\\.014526916133087849\ \(0\)\
\-\ flow\\:\\ 0\\.014445288372677834\ \(0\)\
\-\ determining\\:\\ 0\\.014418068014369699\ \(0\)\
\-\ tends\\:\\ 0\\.014418068014369699\ \(0\)\
\-\ surrounding\\:\\ 0\\.01436913178703205\ \(0\)\
\-\ large\\:\\ 0\\.0143366426994712\ \(0\)\
\-\ carcinomas\\:\\ 0\\.014023820751384385\ \(0\)\
\-\ unlike\\:\\ 0\\.013763506955195275\ \(0\)\
\-\ image\\:\\ 0\\.013653141515588753\ \(0\)\
\-\ attached\\:\\ 0\\.01298682558998243\ \(0\)\
\-\ primary\\:\\ 0\\.012948257099210724\ \(0\)\
\-\ scarring\\:\\ 0\\.012754161195594383\ \(0\)\
\-\ punctate\\:\\ 0\\.012754161195594383\ \(0\)\
\-\ c\\.\\:\\ 0\\.012645313076876235\ \(0\)\
\-\ hepatitis\\:\\ 0\\.012540908998819315\ \(0\)\
\-\ attempt\\:\\ 0\\.012540908998819315\ \(0\)\
\-\ when\\:\\ 0\\.012518318350977012\ \(0\)\
\-\ lymphoma\\:\\ 0\\.012492064626033176\ \(0\)\
\-\ extremely\\:\\ 0\\.012440600269527036\ \(0\)\
\-\ largest\\:\\ 0\\.012391883658348792\ \(0\)\
\-\ region\\:\\ 0\\.012345786328589835\ \(0\)\
\-\ state\\:\\ 0\\.012344077691565791\ \(0\)\
\-\ contrast\\-enhanced\\:\\ 0\\.012251065813890918\ \(0\)\
\-\ blood\\:\\ 0\\.011930491419484908\ \(0\)\
\-\ capsule\\:\\ 0\\.01183085340649635\ \(0\)\
\-\ section\\:\\ 0\\.011717166034192428\ \(0\)\
\-\ particular\\:\\ 0\\.011717166034192428\ \(0\)\
\-\ than\\:\\ 0\\.011452935319275059\ \(0\)\
\-\ longitudinal\\:\\ 0\\.011436606143511035\ \(0\)\
\-\ equal\\:\\ 0\\.011436606143511035\ \(0\)\
\-\ h\\/o\\:\\ 0\\.011403605108125082\ \(0\)\
\-\ radiologic\\:\\ 0\\.011371024479538305\ \(0\)\
\-\ subcutaneous\\:\\ 0\\.011371024479538305\ \(0\)\
\-\ needle\\:\\ 0\\.011124323031488274\ \(0\)\
\-\ next\\:\\ 0\\.011095093630404838\ \(0\)\
\-\ suggests\\:\\ 0\\.01092640317569436\ \(0\)\
\-\ hyperechoic\\:\\ 0\\.01092640317569436\ \(0\)\
\-\ hyperplasia\\:\\ 0\\.01076815406132585\ \(0\)\
\-\ higher\\:\\ 0\\.01071750795570902\ \(0\)\
\-\ poorly\\:\\ 0\\.010667845332033571\ \(0\)\
\-\ smaller\\:\\ 0\\.010595114039653688\ \(0\)\
\-\ doppler\\:\\ 0\\.010571322754072325\ \(0\)\
\-\ enhance\\:\\ 0\\.010571322754072325\ \(0\)\
\-\ observed\\:\\ 0\\.010478310876397452\ \(0\)\
\-\ rather\\:\\ 0\\.010388563255396763\ \(0\)\
\-\ scattered\\:\\ 0\\.010177075491087009\ \(0\)\
\-\ be\\:\\ 0\\.010110665396500735\ \(0\)\
\-\ regions\\:\\ 0\\.010000623134342888\ \(0\)\
\-\ margins\\:\\ 0\\.00992594498934989\ \(0\)\
\-\ removed\\:\\ 0\\.009853385661653686\ \(0\)\
\-\ pe\\:\\ 0\\.009817863635667324\ \(0\)\
\-\ contrast\\:\\ 0\\.009784018858352457\ \(0\)\
\-\ smooth\\:\\ 0\\.00956609874356182\ \(0\)\
\-\ relatively\\:\\ 0\\.009351568093994808\ \(0\)\
\-\ metastases\\:\\ 0\\.00933691163693858\ \(0\)\
\-\ multiple\\:\\ 0\\.009206168815750737\ \(0\)\
\-\ best\\:\\ 0\\.009194789255468475\ \(0\)\
\-\ nodular\\:\\ 0\\.009167288509237627\ \(0\)\
\-\ adenoma\\:\\ 0\\.009126584019964227\ \(0\)\
\-\ same\\:\\ 0\\.0090082189238926\ \(0\)\
\-\ slightly\\:\\ 0\\.008834338256411951\ \(0\)\
\-\ shown\\:\\ 0\\.008763290777877231\ \(0\)\
\-\ is\\:\\ 0\\.008628502993115995\ \(0\)\
\-\ note\\:\\ 0\\.0084349501982143\ \(0\)\
\-\ pattern\\:\\ 0\\.008354072478443168\ \(0\)\
\-\ its\\:\\ 0\\.008246883487098828\ \(0\)\
\-\ commonly\\:\\ 0\\.008246883487098828\ \(0\)\
\-\ confirmed\\:\\ 0\\.008218413307127359\ \(0\)\
\-\ metastasis\\:\\ 0\\.008180939453452498\ \(0\)\
\-\ throughout\\:\\ 0\\.008180939453452498\ \(0\)\
\-\ \\‚\\Ä\\ú\\:\\ 0\\.00816240643933289\ \(0\)\
\-\ which\\:\\ 0\\.008159307351624292\ \(0\)\
\-\ appears\\:\\ 0\\.008134856319174549\ \(0\)\
\-\ calcifications\\:\\ 0\\.008125738502897066\ \(0\)\
\-\ \\‚\\Ä\\ù\\:\\ 0\\.008116653076798938\ \(0\)\
\-\ non\\-contributory\\:\\ 0\\.008071703857306592\ \(0\)\
\-\ calcification\\:\\ 0\\.007932955545926162\ \(0\)\
\-\ biopsy\\:\\ 0\\.00775369115508123\ \(0\)\
\-\ complete\\:\\ 0\\.007691498552394002\ \(0\)\
\-\ because\\:\\ 0\\.00764582689663951\ \(0\)\
\-\ to\\:\\ 0\\.007645720611511263\ \(0\)\
\-\ \\,\\:\\ 0\\.007615884196138519\ \(0\)\
\-\ benign\\:\\ 0\\.00754232830443274\ \(0\)\
\-\ masses\\:\\ 0\\.007387704342700991\ \(0\)\
\-\ size\\:\\ 0\\.007327048264395835\ \(0\)\
\-\ often\\:\\ 0\\.006973078129206272\ \(0\)\
\-\ differential\\:\\ 0\\.006938516187603401\ \(0\)\
\-\ enhancing\\:\\ 0\\.006854101107122147\ \(0\)\
\-\ the\\:\\ 0\\.006717995931889744\ \(0\)\
\-\ show\\:\\ 0\\.006708838707139709\ \(0\)\
\-\ usually\\:\\ 0\\.006636645150554372\ \(0\)\
\-\ through\\:\\ 0\\.006207051198007337\ \(0\)\
\-\ secondary\\:\\ 0\\.006110051065239918\ \(0\)\
\-\ however\\:\\ 0\\.006085340295644682\ \(0\)\
\-\ are\\:\\ 0\\.005958434130586198\ \(0\)\
\-\ one\\:\\ 0\\.005922586658083489\ \(0\)\
\-\ lobe\\:\\ 0\\.005880627488295484\ \(0\)\
\-\ \\:\\:\\ 0\\.00578145685928729\ \(0\)\
\-\ evidence\\:\\ 0\\.005730032182523984\ \(0\)\
\-\ these\\:\\ 0\\.005687582332372993\ \(0\)\
\-\ consistent\\:\\ 0\\.005358819101870085\ \(0\)\
\-\ increased\\:\\ 0\\.005346508393349504\ \(0\)\
\-\ or\\:\\ 0\\.005122878511323313\ \(0\)\
\-\ imaging\\:\\ 0\\.005120393412929931\ \(0\)\
\-\ most\\:\\ 0\\.0050456141732175865\ \(0\)\
\-\ small\\:\\ 0\\.005034719397394165\ \(0\)\
\-\ diagnosis\\:\\ 0\\.005018463761586752\ \(0\)\
\-\ can\\:\\ 0\\.004957090415521917\ \(0\)\
\-\ lower\\:\\ 0\\.004915248259242616\ \(0\)\
\-\ in\\:\\ 0\\.004310969106294168\ \(0\)\
\-\ within\\:\\ 0\\.004169134036793048\ \(0\)\
\-\ normal\\:\\ 0\\.0034261188097163713\ \(0\)\
\-\ as\\:\\ 0\\.003305824823258639\ \(0\)\
\-\ of\\:\\ 0\\.0032776005339587534\ \(0\)\
\-\ there\\:\\ 0\\.0032524694538746514\ \(0\)\
\-\ from\\:\\ 0\\.0032389660182972186\ \(0\)\
\-\ and\\:\\ 0\\.0032226676218044224\ \(0\)\
\-\ a\\:\\ 0\\.003042965231344767\ \(0\)\
\-\ mass\\:\\ 0\\.0030395422172571985\ \(0\)\
\-\ was\\:\\ 0\\.0025275639954314244\ \(0\)\
\-\ left\\:\\ 0\\.002445282018600805\ \(0\)\
\-\ no\\:\\ 0\\.002200624426352435\ \(0\)\
\-\ \\(\\:\\ 0\\.0018474724456364721\ \(0\)\
\-\ \\)\\:\\ 0\\.0018249045834099877\ \(0\)\
\-\ \\.\\:\\ 0\\.0017250413960347294\ \(0\)\
\-\ with\\:\\ 0\\.0011969736684387699\ \(0\)\
